Singapore, Mar 3, 2009: Korea National Institute of Health under the Centers for Disease Control and Prevention (CDC) has collaborated with Bioneer to develop Norovirus Diagnostic kits.
Many researchers in the National Institute of Health have concentrated in finding Norovirus for past six months and that specific target gene of Norovirus that the researchers had discovered, Bioneer developed the diagnostic kits for that certain target. Bioneer and the National Institute of Health have collaborated together to improve and verify the efficiencies as well as minimize the work process. They have proved in the outstanding test results in comparison experiment with those kits supplied by various diagnostic expert companies from different countries. Bioneer’s Excycler 96 will be placed along with diagnostic kits for Norovirus in KFDA. The molecular diagnostic analysis can be done much faster and more accurate at an early stage by using Bioneer’s Exicycler Real-Time Quantitative Thermal Block.
Norovirus is a pathogen that it is highly contagious to cause outbreaks of gastroenteritis. Norovirus has the strong nature to activate even in low temperature that could contaminate food. According to the report in KFDA last winter, among the food contamination that had been filed, approximately 60% were Norovirus that the importance of diagnosis and prevention has become crucial. Norovirus testing will be taking place at least 30,000 tests per year in National Institute of Health and Korea Health and Environment Institute located 17 different locations throughout Korea.
Bioneer said in its prepared release that it is planning to expand in supplying Norovirus diagnostic kits and instruments to those organizations demanding Norovirus tests to KFDA, CDC and Korea Water Resources Corporation. The following Norovirus collaboration with CDC, Bioneer is also finalizing the development of Enterovirus diagnostic kit and Bioneer is planning to develop other target pathogen kits.
From the basis of long experiences and technology that Bioneer possess in genomic research development and products, Bioneer has introduced molecular diagnostic products from July 2008 and so far, it has seen the great outcome. With expansion of clinical diagnostic market, Bioneer is planning to emphasize in supporting especially Health Center, CDC, Quality Inspection Services and various national government organization. Bioneer has developed the total system for Molecular diagnostics from basic materials to instruments and kits and moreover, depending on the project that the organizations have, Bioneer is developing to the instruments and the kits that can be customized that can be used for various targets upon a request from different organizations. Norovirus collaboration between Korea National Institute of Health and Bioneer will be a significant example to expand the global market.
| 
Comment on this article
